IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Citius Pharmaceuticals Inc

CUSIP: 17322U116 | 4 institutional holders

Quarters

Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2022

Susquehanna International Group, LLP15,871
0.0% of portfolio›$2
UBS Group AG117
0.0% of portfolio›$0
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Susquehanna International Group, LLP
15,871$20.0%GrowthHighBala Cynwyd, PA2022-08-15
UBS Group AG
117$00.0%CoreMediumZurich, Switzerland2022-08-10
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2022-08-09